Document Detail

Potential teratogenic effects of allopurinol: a case report.
MedLine Citation:
PMID:  21815259     Owner:  NLM     Status:  MEDLINE    
We report on a case of a multiple congenital anomalies in a newborn infant whose mother was on allopurinol treatment through the pregnancy. The pattern of congenital anomalies that was noted in our patient was similar to the pattern described in a number of published reports following mycophenolate mofetil [CellCept®] treatment during pregnancy. The anomalies present in our patient include: diaphragmatic hernia, unilateral microtia and absence of external auditory canal, micrognathia, microphthalmia, optic nerve hypoplasia, hypoplasia of the corpus callosum, unilateral renal agenesis, pulmonary agenesis, and cleft lip and palate. Since both allopurinol and mycophenolate mofetil act by disrupting purine biosynthesis and given the similarities in anomalies seen after prenatal exposure, we suggest that allopurinol should also be considered a teratogen.
Mariya Kozenko; David Grynspan; Titi Oluyomi-Obi; Daniel Sitar; Alison M Elliott; Bernard N Chodirker
Related Documents :
17922699 - The placental barrier in allogenic immune conflict in spontaneous early abortions: immu...
20104599 - Epidemiology of holoprosencephaly: prevalence and risk factors.
11642779 - Unfinished feticide: a legal commentary.
17385379 - Estimating the incidence of abortion in pakistan.
18772079 - Who is excluded when abortion access is restricted to twelve weeks? evidence from maput...
24503519 - Extended first-trimester screening using multiple sonographic markers and maternal seru...
12535289 - Reproducibility of repeated measurements on post-burn scars with dermascan c.
19717779 - Effects of acclimation to human interaction on performance, temperament, physiological ...
23897619 - Development of severe pathology in immunized pregnant mice challenged with lethal malar...
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2011-08-03
Journal Detail:
Title:  American journal of medical genetics. Part A     Volume:  155A     ISSN:  1552-4833     ISO Abbreviation:  Am. J. Med. Genet. A     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-08-19     Completed Date:  2012-02-09     Revised Date:  2013-05-29    
Medline Journal Info:
Nlm Unique ID:  101235741     Medline TA:  Am J Med Genet A     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2247-52     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 Wiley-Liss, Inc.
Department of Pediatrics & Child Health and Biochemistry, University of Manitoba, Winnipeg, Manitoba, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Abnormalities, Drug-Induced / etiology*
Abnormalities, Multiple / chemically induced*
Allopurinol / adverse effects*,  therapeutic use
Antimetabolites / adverse effects,  therapeutic use
Infant, Newborn
Kidney Calculi / drug therapy
Mycophenolic Acid / adverse effects,  analogs & derivatives
Pregnancy Complications / drug therapy
Prenatal Exposure Delayed Effects
Purines / antagonists & inhibitors,  biosynthesis
Reg. No./Substance:
0/Antimetabolites; 0/Purines; 0/Teratogens; 24280-93-1/Mycophenolic Acid; 315-30-0/Allopurinol; 9242ECW6R0/mycophenolate mofetil

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Homozygous microdeletion of the POU1F1, CHMP2B, and VGLL3 genes in chromosome 3-A novel syndrome.
Next Document:  Monozygotic twin discordance for phacomatosis cesioflammea further supports the post-zygotic mutatio...